Company
Headquarters: Sapporo, Japan
Employees: 10,810
CEO: Mr. Jun Tsuruha
¥537.39 Billion
JPY as of July 1, 2025
US$3.75 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Tsuruha Holdings Inc. operates drugstores in Japan. It sells pharmaceutical and cosmetic products. As of October 15, 2021, the company operated 2,448 stores in Japan and 22 stores in Thailand. The company was founded in 1929 and is headquartered in Sapporo, Japan.
| Last Financial Reports Date | May 31, 2024 |
| Revenue TTM | ¥1.099 T |
| EBITDA | ¥50.54 B |
| Gross Profit TTM | ¥334.35 B |
| Profit Margin | 1.40% |
| Operating Margin | 3.60% |
| Quarterly Revenue Growth | -1.95% |
Tsuruha Holdings, Inc. has the following listings and related stock indices.
Stock: JPX: 3391 wb_incandescent
Stock: OTC: TSUSF wb_incandescent